Business Betting big on anti-pneumonia, anti-urinary infection drug, says Wockhardt’s Khorakiwala Updated : April 20, 2020 03:39 PM IST WCK 6777 is Wockhardt’s sixth antibiotic drug under development, and will shortly enter phase 1 of clinical trials. It will be another 3-4 years before the drug can be filed with USFDA for commercial use. Subscribe to Moneycontrol PRO at just Rs.33/- per month for the first year. Use code SUPERPRO. Limited period offer. Available on Web and Android.